Douglas Lowery, MD
Orthopaedic Surgery · Newburgh, INNPI 1942203641
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $38,995 of the $52,583 with a category attached, or 74.2%. Exactech, Inc. accounts for 67.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $32,706 and has fallen 99.0% since, to $316 in 2025.
Across 64 payments — averaging $821.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exactech, Inc.$35K
- Medical Device Business Services, Inc.$11K
- Zimmer Biomet$4K
- Medacta USA, Inc.$687
- Johnson & Johnson$624
- Linkbio Corp$142
- plus $54 from 2 others
What the payments were for
- Consulting fees$38,99574%
- Travel & lodging$11,22821%
- Food & beverage$2,2674%
- Education$940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exactech, Inc. | 19 | $35,380 |
| Medical Device Business Services, Inc. | 8 | $11,380 |
| Zimmer Biomet | 6 | $4,318 |
| Medacta USA, Inc. | 4 | $687 |
| Johnson & Johnson | 24 | $624 |
| Linkbio Corp | 1 | $142 |
| Shoulder Innovations, Inc. | 1 | $29 |
| Smith+Nephew | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$52,583 in reported general payments places this provider in the 85th percentile of 400 orthopaedic surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 93 | $655 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 44 | $499 |
| Oxycodone Hcl | 68 | $421 |
| Diclofenac Sodium | 12 | $248 |
| Ondansetron Hcl | 13 | $221 |
| Methylprednisolone | 27 | $174 |
| Morphine Sulfate ErMorphine Sulfate | 18 | $77 |
| Amoxicillin | 83 | $68 |
| Tramadol Hcl | 21 | $63 |
| Meloxicam | 37 | $55 |
| Clindamycin Hcl | 43 | $32 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Newburgh
- Anthony CzaplickiNewburgh$38K
- Frank KolisekGreenwood$7.5M
- David FisherIndianapolis$5.9M
- Michael BerendIndianapolis$4M
- John WilliamsFort Wayne$2.7M
- Sanford KunkelIndianapolis$1.9M
- Hill HastingsIndianapolis$1.6M
- Mark KlaassenElkhart$1.3M
- Alan McGeeFort Wayne$1.1M
- Lindsey RolstonNew Castle$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.